Division of Clinical Research and Training

Sl No. Title Authors Journal Name Publication Year
1 Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, et al. Lancet 2016
2 Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, et al. N Engl J Med 2016
3 Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America Carrillo-Larco RM, Miranda JJ, Li X, Cui C, Xu X, Ali M, Alam DS, Gaziano TA, Gupta R, Irazola V, Levitt NS, Prabhakaran D, Rubinstein A, Steyn K, Tandon N, Xavier D, Wu Y, Yan LL Glob Heart 2016
4 Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, Commerford P, Jansky P, Avezum A, Sigamani A, Demasceno A, Reilly P, Grinvalds A, Nakamya J, Aje A, Almahmeed W, Moriarty A, Wallentin L, Yusuf S, Connolly SJ Lancet 2016
5 Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, et al. N Engl J Med 2016
6 Training and Capacity Building in LMIC for Research in Heart and Lung Diseases: The NHLBI-UnitedHealth Global Health Centers of Excellence Program Bloomfield GS, Xavier D, Belis D, Alam D, Davis P, Dorairaj P, Ghannem H, Gilman RH, Kamath D, et al. Glob Heart 2016
7 Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, et al. N Engl J Med 2016
8 A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale Rao MP, Ciobanu AO, Lopes RD, Fox KA, Xian Y, Pokorney SD, Al-Khalidi HR, Jiang J, Kamath DY, Berwanger O, Xavier D, Bahit CM, Tajer C, Vinereanu D, Huo Y, Granger CB Am Heart J 2016
9 Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gaziano T, Levitt NS, Miranda JJ, Ortiz AB, Steyn K, Wu Y, Xavier D, Yan LL, He J, Rubinstein A Glob Heart 2016
10 Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial Jaspers Focks J, Brouwer MA, Wojdyla DM, Thomas L, Lopes RD, Washam JB, Lanas F, Xavier D, Husted S, Wallentin L, Alexander JH, Granger CB, Verheugt FW BMJ 2016
11 Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial Xavier D, Gupta R, Kamath D, Sigamani A, Devereaux PJ, George N, Joshi R, Pogue J, Pais P, Yusuf S Lancet Diabetes Endocrinol 2016
12 Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations Gaziano TA, Abrahams-Gessel S, Alam S, Alam D, Ali M, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gutierrez L, Irazola V, Levitt NS, Miranda JJ, Bernabe-Ortiz A, Pandya A, Rubinstein A, Steyn K, Xavier D, Yan LL Glob Heart 2016
13 High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective Kamath DY, Xavier D, Sigamani A, Pais P Indian J Med Res 2015
14 Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L Am Heart J 2015
15 Age-specific and sex-specific adult mortality risk in India in 2014: analysis of 0·27 million nationally surveyed deaths and demographic estimates from 597 districts Ram U, Jha P, Gerland P, Hum RJ, Rodriguez P, Suraweera W, Kumar K, Kumar R, Dikshit R, Xavier D, Gupta R, Gupta PC, Ram F Lancet Glob Health 2015

Pages